RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, will be presenting at the UBS 2011 Global Specialty Pharmaceuticals Conference. The Conference will take place May 24-25, 2011 in London.
